Moleculin Biotech Inc (MBRX)

NASDAQ
3.78
-0.14(-3.57%)
After Hours
3.77
-0.01(-0.2646%)
- Real-time Data
  • Volume:
    243,347
  • Bid/Ask:
    3.77/3.80
  • Day's Range:
    3.74 - 3.90

MBRX Overview

Prev. Close
3.92
Day's Range
3.74-3.9
Revenue
-
Open
3.895
52 wk Range
3.12-9.3
EPS
-1.8
Volume
243,347
Market Cap
107.52M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,147,652
P/E Ratio
-
Beta
1.97
1-Year Change
-41.67%
Shares Outstanding
28,444,425
Next Earnings Date
Aug 16, 2021
What is your sentiment on Moleculin Biotech Inc?
or
Market is currently closed. Voting is open during market hours.

Moleculin Biotech Inc News

Moleculin Biotech Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellSellSellBuy
Technical IndicatorsStrong BuySellStrong SellBuyStrong Buy
SummaryStrong SellStrong SellStrong SellNeutralStrong Buy

Moleculin Biotech Inc Company Profile

Moleculin Biotech Inc Company Profile

Employees
10

Moleculin Biotech, Inc. is a clinical-stage pharmaceutical company. The Company is focused on the treatment of cancers. Its clinical stage drug candidates include Annamycin, WP1066, WP1220, WP1732, WP1122 and WP1234. Annamycin is intended for the treatment of relapsed or refractory acute myeloid leukemia (AML) and cancers metastasized to the lungs. WP1066 is an immune/transcription modulator (p-STAT3 inhibitor) and is intended to target a wide range of tumors, including brain tumors and pancreatic cancer. WP1220 is intended for the topical treatment of cutaneous T-cell lymphoma (CTCL). WP1732 is evaluated for the potential treatment of AML, pancreatic and other cancers. WP1122 and WP1234 are evaluated for the potential to treat brain tumors and pancreatic cancer through its ability to inhibit glycolysis. It is also engaged in development of drug candidates, including additional immune/transcription modulators, as well as metabolism/glycosylation inhibitors.

Read More
  • Come on with that price target :o)
    0
    • Nobody cares about today's news?
      0
      • what are your tots on MBRX today?
        0
        • Yikes
          1
          • I'm grabbing a few more...
            0
            • good dip!
              0
              • Moleculin Announces 100% Survival Achieved in Osteosarcoma Lung Metastases Animal Model
                0
                • https://finance.yahoo.com/news/moleculin-announces-100-survival-achieved-123000065.html
                  0
                  • hey guys who ever done from here go and buy (aumn)
                    0
                    • reverse stock split?
                      0
                      • yep *6
                        0
                      • jeanfrancois martin now it makes sense haha
                        0
                      • What does “reverse stock split” mean?
                        0
                    • Damn RS, smh!
                      0
                      • BioConnect 2021 Conference being held January 11-14 !!!
                        0
                        • Buy now!!! Going 5$
                          0
                          • You weren't wrong...
                            0
                        • good 👍 stock to buy
                          0
                          • Just own it, don't trade it.  It is under serious accumulation.
                            0
                            • This company is for real.  Partnerships with the big boys and a pipeline that is impressive.  This could very well be the one that becomes a 100 bagger in a few years.  Buy it and don't even look.  Forget you own it.  Look when it hits $50.  Don't sell it there, but look.  Be able to say you bought it under $1.
                              0
                              • The target is 3.33
                                0
                                • https://www.marketwatch.com/press-release/moleculin-announces-successful-completion-of-pre-ind-meeting-with-the-fda-2020-09-09?mod=mw_quote_news
                                  0
                                  • Movement
                                    0
                                    • what?
                                      0
                                    • what?
                                      0
                                  • Any new info on this stock?
                                    0
                                    • https://www.sciencedirect.com/science/article/pii/S155041312030365X?via%3Dihub
                                      0
                                      • MBRX when will go up ?? Lets go baby
                                        0
                                        • MBRX $1.25 @ 11:47 AM ET
                                          0
                                          • Moleculin's WP1122 shows anti-SARS-CoV-2 effect in new lab tests Jul. 21, 2020 8:54 AM ET|About: Moleculin Biotech, Inc. (MBRX)|By: Vandana Singh, SA News Editor  Moleculin Biotech (NASDAQ:MBRX) rises ~35% PM in reaction to independent laboratory testing that confirms antiviral activity of WP1122 against coronavirus. The testing compared the therapeutic effects of 2-DG (the active ingredient in WP1122) alone with those of WP1122, a 2-DG prodrug. Additionally, the Company has also contracted with the independent lab to conduct preclinical toxicology testing, which is currently under way. Last month, the company announced repeat testing of candidate WP1122 confirmed its antiviral potential. WP1122 is a prodrug of 2-deoxy-D-glucose (2-DG). WP1122 is only metabolized once it is inside the cell, enabling much higher tissue and organ concentrations of 2-DG.
                                            0
                                            • August 17th the quarterly reports come out
                                              0
                                              • Sergio Araque  Do your research, trust your instinct and you will know what to do.
                                                0
                                              • holding it depends on whether you can afford to lose the money.. tbh.. i would get out with any profit you can.. because in the end.. if they don't deliver a vaccine.. its gonna drop.. and no ones buying..
                                                0
                                              • Johnny Thunder As i understand they are not developing a vaccine, but an antiviral treatment which might help infected people. A vaccine is far away, either at the end of this year or first quarter of next year. Until than, they need a treatment if the number of cases keep rising.
                                                0
                                            Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                            Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.